Documents & Downloads

GSK217

BD2 Inhibitor

GSK217 is a selective inhibitor targeting the second bromodomain (BD2) of the bromodomain and extraterminal domain (BET) proteins. This compound offers potent activity and high solubility, making it suitable for investigations in oncology and immune inflammation research. Its ability to modulate BET protein interactions positions GSK217 as a valuable tool for exploring therapeutic strategies in cancer and inflammation-related pathways.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	2748687-92-3
Applications	BD2 Inhibitor
Formula	C₂₀H₂₀N₆O
Molecular Weight	360.41
SMILES	O=C(C1=CC(C2=CN(C)N=N2)=NC(CC3=C4C=CNC4=CC=C3)=C1)NCC

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.